Further in vivo experiments, which in this study are lacking, using stably TENM4 knock out murine TNBC cells that we have recently obtained by exploiting the CRISPR/Cas9 technology will help us to better define the role of TENM4 on tumor initiation and progression. Here, TENM4 is linked to neoplasm.